Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Bioavailability of Proteins From Plant Based Diets

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03492190
Recruitment Status : Unknown
Verified May 2018 by Eduardo Ferriolli, University of Sao Paulo.
Recruitment status was:  Not yet recruiting
First Posted : April 10, 2018
Last Update Posted : May 4, 2018
Sponsor:
Information provided by (Responsible Party):
Eduardo Ferriolli, University of Sao Paulo

Brief Summary:
The quality of protein intake has an important role within the nutritional needs of people throughout their lives around the world, particularly in developing countries and in particular during pregnancy and early childhood. It is likely that adequate protein reduce by 40% the prevalence of stunting (low height for age) in children under five years, according to World Health Organization data. Uncertainty about the quality of the diet, specifically with reference to quality proteins has potential impacts on health, economy, agriculture, and food security of a nation. The amino acid digestibility estimates based on stool analysis do not represent the amount of absorbed amino acid. Ideally, the bioavailable amino acid should be measured by methods that assess the difference between consumed and absorbed amino acids. However, the uptake of amino acids is not readily non-invasively measured in healthy humans. The use of vegetable protein intrinsically labeled by stable isotopes offers a solution to this problem. The deuterated water (2H2O), with relatively low cost, is suitable for labeling plant proteins such as those of beans. The labeled amino acids are present in the test meal ingested and incorporated into the blood, representing a single measure of bioavailability. This study aims to develop and apply a new methodology, using stable isotopes, to evaluate the bioavailability of bean protein, a very important food in the Brazilian diet, according to cooking procedures, through the use of deuterium. The project will be divided into two parts: a human nutrition and an agriculture part, the latter by planting/harvesting deuterium-labeled Phaseolus vulgaris L. After two weeks of blooming, deuterium water will be added to the bean crop, which will be subsequently dried. Chemical analysis and assessment of incorporation of deuterium in the beans will be done. Concurrent with the cultivation of beans, there will be a protein absorption test with 15 healthy volunteers for validation of the methods. For comparison purposes, milk protein labeled with deuterium and C13 will be used. The volunteers will consume the test meals. Blood, urine and saliva samples will be collected at baseline (before food ingestion), and in different times after the meal. In the next phase of this research, labeled beans produced by the agriculture experiment will be used to measure the protein absorption of volunteers of different groups (older persons, and stunting and non-stunting children). The samples will analyzed by isotope-ratio mass spectrometry. This methodology may promote a better understanding of the absorption of proteins and amino acids using less invasive methods in different age groups and clinical conditions. This work will have an important impact for the general population as well as for agriculture and health-related professionals.

Condition or disease
Protein Malabsorption Nutrition Disorders Sarcopenia

Show Show detailed description

Layout table for study information
Study Type : Observational
Estimated Enrollment : 45 participants
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Bioavailability of Proteins From Beans Usually Consumed in the Brazilian Diet (Phaseolus Vulgaris) According to Different Preparation Techniques.
Estimated Study Start Date : July 1, 2018
Estimated Primary Completion Date : August 23, 2018
Estimated Study Completion Date : December 31, 2020

Group/Cohort
adults

Select the individual:

Healthy, non-pregnant adults 18-65 years of age, not taking any medication, including NSAIDs, not taking antibiotics within 4 weeks of study, BMI within 18-35 range and stable weight.

Exclusion criteria: children and elderly (over 65), pregnancy, diagnosed with non-communicable or communicable disease, being under restrictive diet, antibiotics within 4 weeks of study, medications within 4 weeks of study. They will eat beans for 5 days. The beans will be soaked for 3 h, water discarded and beans cooked for 20 min in pressure cook. And in the end for the week, adults will be eat the bean enrichment of deuterium for availability protein, collected urine, saliva and blood.

Children

Fifty children will be recruited from ages varying from 1 to 3 years and of both sexes. Children who use medications, who do not habitually consume beans, will be excluded and when there is no explicit written authorization from the parents or guardians.

All the children with different status of nutrition will be eaten the beans. They will eat beans for 5 days. The beans will be soaked for 3 h, water discarded and beans cooked for 20 min in pressure cook. And in the end for the week, children will be eat the bean enrichment of deuterium for availability protein, collected urine or saliva depend on the best biological samples of pilot study (adult).

Elderly
Fifty individuals of both sexes will be recruited, previously evaluated by complete clinical / laboratory examination and medical history. The elderly will be excluded from antiinflammatory, chemotherapeutic, corticoid, allergy and bean aversion or antibiotic therapy. These drugs could interfere with protein bioavailability. They will eat beans for 5 days. The beans will be soaked for 3 h, water discarded and beans cooked for 20 min in pressure cook. And in the end for the week, elderly will be eat the bean enrichment of deuterium for availability protein, collected urine or saliva depend on the best biological samples of pilot study (adult).



Primary Outcome Measures :
  1. Bioavailability protein using deuterium [ Time Frame: It will be collected for 1 day ]
    Il will be measured new stable isotope method using deuterium for the study of the bioavailability of protein derived from beans in healthy adults, children and elderly. It will be assessed 45 persons, express in delta enrichment and analysis in Mass Spectrometry


Secondary Outcome Measures :
  1. Bioavailability protein using carbon 13 [ Time Frame: It will be collected for 1 day ]
    Il will be measured stable isotope using Carbon 13 for the study of the bioavailability of protein derived from beans in healthy adults, children and elderly. It will be assessed 45 persons, express in delta enrichment and analysis in Mass Spectrometry

  2. Nutritional composition [ Time Frame: through study completion in 1 week ]
    3 samples for beans cooked will be collected and will be verified the nutrients composition properties of the usually consumed Brazilian bean (Phaseolus vulgaris) labelled with deuterium like macronutrients and micronutrients in grams.


Other Outcome Measures:
  1. Total urinary nitrogen [ Time Frame: It will be collected for 1 day ]
    Urinary nitrogen of the samples will be analysed by the Kjeldahl method with ammonium micro diffusion



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Select healthy person with inclusion criteria
Criteria

Inclusion Criteria:

  • Healthy, non-pregnant adults 18-65 years of age

    • Not taking any medication, including NSAIDs
    • Not taking antibiotics within 4 weeks of study
    • BMI within 18-35 range
    • Stable weight

Exclusion Criteria:

  • Children and elderly (over 65)

    • Pregnancy
    • Diagnosed with non-communicable or communicable disease
    • Being under restrictive diet
    • Antibiotics within 4 weeks of study
    • Medications within 4 weeks of study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03492190


Contacts
Layout table for location contacts
Contact: Karina Pfrimer, PhD +551633153370 kpfrimer@fmrp.usp.br

Sponsors and Collaborators
Eduardo Ferriolli
Investigators
Layout table for investigator information
Principal Investigator: Eduardo Ferriolli, PhD São Paulo University, School of Medicine
Publications:
Layout table for additonal information
Responsible Party: Eduardo Ferriolli, Assistant professor, University of Sao Paulo
ClinicalTrials.gov Identifier: NCT03492190    
Other Study ID Numbers: 2207
First Posted: April 10, 2018    Key Record Dates
Last Update Posted: May 4, 2018
Last Verified: May 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: There is no plan to make this data available to other researchers. We will publish this data in the scientific magazine

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Eduardo Ferriolli, University of Sao Paulo:
protein availability
beans
children
elderly
Additional relevant MeSH terms:
Layout table for MeSH terms
Malabsorption Syndromes
Sarcopenia
Nutrition Disorders
Muscular Atrophy
Neuromuscular Manifestations
Neurologic Manifestations
Nervous System Diseases
Atrophy
Pathological Conditions, Anatomical
Intestinal Diseases
Gastrointestinal Diseases
Digestive System Diseases
Metabolic Diseases